Similar articles

• Identification of alpha-adrenergic receptors in human platelets by [3H]dihydroergocryptine binding.

  Newman KD, Williams LT, Bishopric NH, Lefkowitz RJ. Newman KD, et al. J Clin Invest. 1978 Feb;61(2):395-402. doi: 10.1172/JCI108950. J Clin Invest. 1978. PMID: 23392 Free PMC article.
• A comparison of alpha 2-adrenoreceptor binding characteristics of intact human platelets identified by [3H]-yohimbine and [3H]-dihydroergocryptine.

  Boon NA, Elliott JM, Grahame-Smith DG, St John-Green T, Stump K. Boon NA, et al. J Auton Pharmacol. 1983 Jun;3(2):89-95. doi: 10.1111/j.1474-8673.1983.tb00524.x. J Auton Pharmacol. 1983. PMID: 6309852
• [3H]Dihydroergocryptine binding to alpha-adrenergic receptors of human platelets. A reassessment using the selective radioligands [3H]prazosin, [3H]yohimbine, and [3H]rauwolscine.

  Motulsky HJ, Insel PA. Motulsky HJ, et al. Biochem Pharmacol. 1982 Aug 15;31(16):2591-7. doi: 10.1016/0006-2952(82)90705-5. Biochem Pharmacol. 1982. PMID: 6291538
• Platelet alpha-adrenoceptors--a valid model for brain or vascular adrenoceptors?

  Hamilton CA, Reid JL. Hamilton CA, et al. Br J Clin Pharmacol. 1986 Dec;22(6):623-6. doi: 10.1111/j.1365-2125.1986.tb02948.x. Br J Clin Pharmacol. 1986. PMID: 3032225 Free PMC article. Review. No abstract available.
• Placental and blood element neurotransmitter receptor regulation in humans: potential models for studying neurochemical mechanisms underlying behavioral teratology.

  Perry BD. Perry BD. Prog Brain Res. 1988;73:189-205. doi: 10.1016/S0079-6123(08)60505-1. Prog Brain Res. 1988. PMID: 2843946 Review. No abstract available.